Verition Fund Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,910
Closed -$659K 2745
2022
Q1
$659K Buy
+2,910
New +$684K 0.01% 1745

Other funds holding LH

Verition Fund Management's LH Position: Q2 2026 in Review

Verition Fund Management increased its Labcorp (LH) stake by 327% in Q2 2026, buying an estimated $2.81M and bringing the position to 13,960 shares worth $3.91M. The position accounts for 0.02% of the portfolio, ranked #771.

Verition Fund Management first reported a position in LH in Q4 2013 and has held it in 34 quarters since. The position peaked at $24.4M in Q1 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Verition Fund Management held 13,960 shares of Labcorp worth $3.91M as of Q2 2026.
  • Verition Fund Management bought 10,692 Labcorp shares in Q2 2026, an estimated $2.81M.
  • Labcorp made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #771 holding.
  • Verition Fund Management first reported a position in Labcorp in Q4 2013 and has held it in 34 quarters since.
  • Verition Fund Management's Labcorp position peaked at $24.4M in Q1 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.